Subconjunctival injection of bevacizumab for recurrent conjunctival papilloma: a case report

Can J Ophthalmol. 2017 Oct;52(5):e156-e159. doi: 10.1016/j.jcjo.2017.03.011. Epub 2017 May 10.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Angiogenesis Inhibitors / therapeutic use*
  • Bevacizumab / therapeutic use*
  • Conjunctival Neoplasms / drug therapy*
  • Conjunctival Neoplasms / pathology
  • Humans
  • Injections, Intraocular
  • Male
  • Neoplasm Recurrence, Local*
  • Papilloma / drug therapy*
  • Papilloma / pathology
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors

Substances

  • Angiogenesis Inhibitors
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Bevacizumab